Tag: MDMA clinical trials
The Impact of MDMA-Assisted Psychotherapy: Challenges and Progress
A tough weekend for those supporting MDMA-assisted psychotherapy. First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA papers due to data integrity issues. In contrast, a nasal...
Revised Title: Rejection of Three MDMA Treatment Studies by Scientific Journal
Researchers have been studying the use of MDMA, also known as Ecstasy, as a potential treatment for post-traumatic stress disorder (PTSD). However, three papers on MDMA-assisted therapy were recently retracted by the journal Psychopharmacology...
FDA Rejects MDMA for Mental Health Treatment: What This Means for PTSD Therapy
The U.S. Food and Drug Administration (FDA) made an announcement on Friday that they have rejected MDMA as a treatment for PTSD due to significant limitations that prevent them from deeming the drug safe...
Bipartisan Push for MDMA Therapy Gains Support from Veterans and Lawmakers
The Food and Drug Administration (F.D.A.) is on the brink of making a significant decision regarding the therapeutic use of MDMA, commonly known as Ecstasy or Molly, in treating post-traumatic stress disorder (PTSD). This...